Patent · US Active

Recombinant fusion protein and polynucleotide construct for immunotoxin production

US8329183B2 · kind B2 · utility

0Cited by
5References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2011
Grant dateDec 11, 2012
Priority date
Expiry dateSep 15, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/705
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to a polynucleotide construct encoding a fusion protein consisting of a domain which binds the immunoglobulin Fc region, genetically fused to a truncated form of Pseudomonas exotoxin A (PE). In particular, the invention discloses the fusion protein, ZZ-PE38, and further provides immunotoxins, formed from complexes of the fusion protein with antibodies for targeted cell killing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.